Brief: Paion Starts EU Phase III Trial With Remimazolam In General Anesthesia

PAION AG

24/07/2018 09:02

July 24 (Reuters) - PAION AG  PA8G.DE :
    * STARTS EU PHASE III TRIAL WITH REMIMAZOLAM IN GENERAL
ANESTHESIA
    * PATIENT RECRUITMENT EXPECTED TO BE COMPLETED IN 2019
    * PAION - EXPECTS THAT POSITIVE PHASE III TRIAL WITH
PREVIOUSLY
COMPLETED CLINICAL STUDIES IN EUROPE AND JAPAN SHOULD BE
SUFFICIENT FOR FILING FOR MARKET APPROVAL FOR INDICATION OF
GENERAL ANESTHESIA IN EU

Source text for Eikon:  ID:nEQ1tBqMa 
Further company coverage:  PA8G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))